Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Neuropharmacology

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • PACAP regulation of central amygdala GABAergic synapses is altered by restraint stress.  168. 2020
  • Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.  164. 2020
  • Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.  178. 2020
  • Corticotropin releasing factor, but not alcohol, modulates norepinephrine release in the rat central nucleus of the amygdala.  179. 2020
  • Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.  176. 2020
  • Sex differences and Tat expression affect dopaminergic receptor expression and response to antioxidant treatment in methamphetamine-sensitized HIV Tat transgenic mice.  178. 2020
  • Targeting the 5-HT system: Potential side effects.  179. 2020
  • The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.  162. 2020
  • Vaccine blunts fentanyl potency in male rhesus monkeys.  158. 2019
  • Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions.  151:127-135. 2019
  • A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex.  150:46-58. 2019
  • Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.  141:55-65. 2018
  • Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.  141:181-191. 2018
  • Altered brain activity during withdrawal from chronic alcohol is associated with changes in IL-6 signal transduction and GABAergic mechanisms in transgenic mice with increased astrocyte expression of IL-6.  138:32-46. 2018
  • Prophylactic vaccination protects against the development of oxycodone self-administration.  138:292-303. 2018
  • Altered hippocampal synaptic function in transgenic mice with increased astrocyte expression of CCL2 after withdrawal from chronic alcohol.  135:113-125. 2018
  • Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.  134:293-301. 2018
  • Designer drugs - A continuing chemical (R)evolution.  134:1-3. 2018
  • Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.  134:57-64. 2018
  • Morphological and functional evidence of increased excitatory signaling in the prelimbic cortex during ethanol withdrawal.  133:470-480. 2018
  • CRF modulates glutamate transmission in the central amygdala of naive and ethanol-dependent rats.  125:418-428. 2017
  • Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.  125:80-86. 2017
  • P/Q-type voltage -gated calcium channels mediate the ethanol and CRF sensitivity of central amygdala GABAergic synapses.  125:197-206. 2017
  • Cortical and amygdalar neuronal ensembles in alcohol seeking, drinking and withdrawal.  122:107-114. 2017
  • Emerging pharmacotherapies for alcohol use disorder.  122:244-253. 2017
  • Synaptic targets: Chronic alcohol actions.  122:85-99. 2017
  • Sex differences in responses of the basolateral-central amygdala circuit to alcohol, corticosterone and their interaction.  114:123-134. 2017
  • The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.  114:156-167. 2017
  • Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.  116:1-8. 2016
  • Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.  109:112-120. 2016
  • Dependence-induced ethanol drinking and GABA neurotransmission are altered in Alk deficient mice.  107:1-8. 2016
  • Histamine receptor signaling in energy homeostasis.  106:13-19. 2016
  • Histamine receptor signaling in energy homeostasis.  106:13-19. 2016
  • Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function.  103:27-43. 2016
  • Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex.  102:92-102. 2016
  • Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects.  102:21-31. 2016
  • Prioritizing the development of mouse models for childhood brain disorders.  100:2-16. 2016
  • Characterization of kappa opioid receptor mediated, dynorphin-stimulated [(35)S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.  99:131-141. 2015
  • Intravenous self-administration of entactogen-class stimulants in male rats.  99:538-545. 2015
  • Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.  99:600-609. 2015
  • Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.  99:705-714. 2015
  • IL-6 regulation of synaptic function in the CNS.  96:42-54. 2015
  • Intravenous self-administration of mephedrone, methylone and MDMA in female rats.  92:90-97. 2015
  • Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala.  77:294-302. 2014
  • Addiction as a stress surfeit disorder.  76:370-382. 2014
  • Chronic periadolescent alcohol consumption produces persistent cognitive deficits in rhesus macaques.  86:78-87. 2014
  • Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability.  76:533-544. 2014
  • Adult siRNA-induced knockdown of mGlu(7) receptors reduces anxiety in the mouse.  72:66-73. 2013
  • The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats.  71:130-140. 2013
  • Comparison of the effects of the GABA(B) receptor positive modulator BHF177 and the GABA(B) receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.  70:156-167. 2013
  • Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype.  70:211-217. 2013
  • The influence of acute and chronic alcohol consumption on response time distribution in adolescent rhesus macaques.  70:12-18. 2013
  • Enhanced gabaergic transmission in the central nucleus of the amygdala of genetically selected marchigian sardinian rats: Alcohol and crf effects.  67:337-348. 2013
  • New insights on neurobiological mechanisms underlying alcohol addiction.  67:223-232. 2013
  • Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression.  67:115-125. 2013
  • Crebinostat: A novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.  64:81-96. 2013
  • Differences between synaptic plasticity thresholds result in new timing rules for maximizing long-term potentiation.  64:27-36. 2013
  • Mechanism of H₂ histamine receptor dependent modulation of body temperature and neuronall activity in the medial preoptic nucleus.  63:171-180. 2012
  • Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-ht1a, gaba(a), and nmda receptors.  62:1034-1043. 2012
  • Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: Alleviation by crf1 receptor antagonism.  62:1142-1151. 2012
  • Stress modulation of drug self-administration: Implications for addiction comorbidity with post-traumatic stress disorder.  62:552-564. 2012
  • Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects.  62:347-357. 2012
  • Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.  61:1070-1087. 2011
  • Intravenous nicotine self-administration and cue-induced reinstatement in mice: Effects of nicotine dose, rate of drug infusion and prior instrumental training.  61:687-698. 2011
  • The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6- (3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl -1-(tetrahy dro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo 3,4-d pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents.  61:665-676. 2011
  • Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).  60:1187-1192. 2011
  • Mentored and inspired by Mimo: A tribute to Erminio Costa.  60:1003-1006. 2011
  • Structure based prediction of subtype-selectivity for adenosine receptor antagonists.  60:108-115. 2011
  • The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics.  60:58-65. 2011
  • Reduced alcohol drinking in adult rats exposed to sucrose during adolescence.  59:388-394. 2010
  • Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin a poisoned mouse neuromuscular junctions.  58:1189-1198. 2010
  • Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure.  58:185-194. 2010
  • Neurobiological substrates for the dark side of compulsivity in addiction.  56:18-31. 2009
  • The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents.  55:908-918. 2008
  • Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity.  54:475-486. 2008
  • Evaluation of fatty acid amides in the carrageenan-induced paw edema model.  54:181-188. 2008
  • Identification of ginsenoside interaction sites in 5-ht3a receptors.  52:1139-1150. 2007
  • Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice.  50:834-844. 2006
  • Prolonged nicotine exposure does not alter gaba(b) receptor-mediated regulation of brain reward function.  49:953-962. 2005
  • Endocannabinoids restrict hippocampal long-term potentiation via cb1.  49:660-668. 2005
  • Inhibition of cyclooxygenase-2 elicits a cb1-mediated decrease of excitatory transmission in rat ca1 hippocampus.  49:653-659. 2005
  • Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice.  49:493-501. 2005
  • Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.  48:881-893. 2005
  • Coupling of human nicotinic acetylcholine receptors alpha 7 to calcium channels in GH3 cells.  48:215-227. 2005
  • Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.  47:1081-1092. 2004
  • Cathepsin B-like proteolysis and MARCKS degradation in sublethal NMDA-induced collapse of dendritic spines.  47:706-713. 2004
  • The somatostatin receptor (sst(1)) modulates the release of somatostatin in the nucleus accumbens of the rat.  47:612-618. 2004
  • Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina.  45:1080-1092. 2003
  • Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists.  44:672-685. 2003
  • Somatostatin sst(2) receptor knock-out mice: localisation of sst(1-5) receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography.  42:396-413. 2002
  • 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine.  42:170-180. 2002
  • The effect of autonomous alpha-camkii expression on sensory responses and experience-dependent plasticity in mouse barrel cortex.  41:771-778. 2001
  • Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors.  41:282-284. 2001
  • Both gaba(b) receptor agonist and antagonists decreased brain stimulation reward in the rat.  40:676-685. 2001
  • Distinct effect of pregnenolone sulfate on NMDA receptor subtypes.  40:491-500. 2001
  • Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-ht1a and not by muscarinic m-1 receptors.  39:300-307. 2000
  • Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.  39:1451-1462. 2000
  • Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.  38:449-462. 1999
  • No change in NMDA receptor-mediated response rise-time during development: Evidence against transmitter spillover.  37:1393-1398. 1998
  • 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome.  36:419-428. 1997
  • Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: Considerations on receptor effector coupling across systems.  36:429-437. 1997
  • Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat.  35:1811-1814. 1996
  • Actions of redox-related congeners of nitric oxide at the NMDA receptor.  33:1229-1233. 1994
  • Sensitivity of the circadian-rhythm of kainic acid-induced convulsion susceptibility to manipulations of corticosterone levels and mineralocorticoid receptor-binding.  33:1087-1093. 1994
  • The beta-carboline derivative dmcm decreases gamma-aminobutyric-acid responses and ca2+-mediated k+-conductance in rat neocortical neurons in-vitro.  33:875-883. 1994
  • Precipitation of morphine-withdrawal syndrome in rats by administration of mu-selective, delta-selective and kappa-selective opioid antagonists.  31:1231-1241. 1992
  • Effects of dizocilpine (MK-801) and ethanol on the EEG and event-related potentials (ERPS) in rats.  31:369-378. 1992
  • Levels of dynorphin peptides, substance-p and cgrp in the spinal-cord after subchronic administration of morphine in the rat.  30:1219-1223. 1991
  • Subtractive cloning of complementary dnas and analysis of messenger-rnas with regional heterogeneous distributions in primate cortex.  26:845-854. 1987
  • Chemical and physiological-aspects of the actions of lithium and anti-depressant drugs.  22:359-365. 1983
  • Metabolism of h-3 dopamine following intracerebroventricular injection in rats pretreated with ethanol or chloral hydrate.  22:279-286. 1983
  • Benzodiazepine receptors remain unchanged after chronic ethanol administration.  19:125-128. 1980
  • Cooperative interactions of histamine and competitive antagonism by cimetidine at neuronal histamine-receptors in the marine mollusk, Aplysia-californica.  18:415-421. 1979
  • Relationship between pipradrol-induced responding for electrical brain-stimulation, stereotyped behavior and locomotor-activity.  17:363-366. 1978
  • Microiontophoretic release of norepinephrine from micropipettes.  10:175-180. 1971
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0028-3908

Electronic International Standard Serial Number (EISSN)

  • 1873-7064

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support